DENTSPLY SIRONA (NASDAQ:XRAY) Lowered to “Hold” Rating by Leerink Partnrs

Leerink Partnrs downgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY) from a strong-buy rating to a hold rating in a research note released on Thursday morning,Zacks.com reports.

Other research analysts also recently issued research reports about the company. StockNews.com raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Wednesday. Stifel Nicolaus decreased their price objective on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a research note on Thursday, July 18th. Evercore ISI lowered their price objective on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th. Barrington Research decreased their price target on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday. Finally, Needham & Company LLC lowered their price target on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a report on Friday, October 25th. Six investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, DENTSPLY SIRONA has an average rating of “Hold” and a consensus target price of $29.50.

DENTSPLY SIRONA Stock Performance

DENTSPLY SIRONA stock traded up $0.60 during mid-day trading on Thursday, hitting $17.86. 9,705,924 shares of the company’s stock traded hands, compared to its average volume of 3,115,189. DENTSPLY SIRONA has a fifty-two week low of $17.21 and a fifty-two week high of $37.60. The stock has a market cap of $3.62 billion, a price-to-earnings ratio of -8.63, a P/E/G ratio of 1.31 and a beta of 1.02. The firm has a 50 day simple moving average of $24.68 and a two-hundred day simple moving average of $25.90. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.33 and a quick ratio of 0.87.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The company had revenue of $951.00 million during the quarter, compared to analysts’ expectations of $939.10 million. During the same quarter in the previous year, the company posted $0.49 earnings per share. The business’s revenue was up .4% on a year-over-year basis. On average, research analysts expect that DENTSPLY SIRONA will post 1.98 EPS for the current fiscal year.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of institutional investors have recently made changes to their positions in XRAY. Raymond James Trust N.A. increased its position in DENTSPLY SIRONA by 4.9% during the 2nd quarter. Raymond James Trust N.A. now owns 9,658 shares of the medical instruments supplier’s stock valued at $241,000 after purchasing an additional 453 shares during the period. State of Alaska Department of Revenue raised its stake in DENTSPLY SIRONA by 2.4% during the third quarter. State of Alaska Department of Revenue now owns 23,545 shares of the medical instruments supplier’s stock worth $637,000 after buying an additional 560 shares during the last quarter. LRI Investments LLC lifted its holdings in DENTSPLY SIRONA by 82.7% in the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after buying an additional 564 shares during the period. Diversified Trust Co boosted its position in DENTSPLY SIRONA by 3.0% during the second quarter. Diversified Trust Co now owns 19,637 shares of the medical instruments supplier’s stock valued at $489,000 after acquiring an additional 566 shares during the last quarter. Finally, Allworth Financial LP grew its holdings in DENTSPLY SIRONA by 40.2% during the 3rd quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock worth $59,000 after acquiring an additional 625 shares during the period. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.